Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 21 -30 of 557 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer				Phase III				WJTOG0101 NCT00139971
	Trial to Evaluate Radiotherapy With or Without CBDCA in Elderly Patients With Non-Small Cell Lung Cancer (JCOG0301)				Phase III				JCOG0301 C000000059, NCT00132665
	Positron Emission Tomography (PET) Imaging in Stage III Non-Small Cell Lung Cancer (PET START Trial)				Phase III				CTA-Control-087276 NCT00136864
	A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-Small Cell Lung Cancer				Phase III				CZOL446G2419 NCT00172042
	Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)				Phase III				D-0410 NCT00153803
	Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer				Phase III				LLCG-TOPICAL EU-2004-000729-31, ISRCTN77383050, NCT00275132
	Random Trial for Elderly Patients With NSCLC				Phase III				INJE05-06 NCT00265694
	Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC				Phase III				TASMC-05-FB-05235-CTIL NCT00268684
	Neoadjuvant Chemotherapy Plus/Minus Surgery in Non-Small-Cell Lung Cancer (NSCLC) Stage IIIA/N2				Phase III				Surgery in NSCLC stage IIIA/N2 NCT00273494
	Cisplatin, Vinorelbine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery				Phase III				CRUK-SOCCAR ISRCTN13746987, EU-20602, EUDRACT-2004-001920-19, NCT00309972


					< Previous 1 2 3 4 5 6 Next >

| | | | | | | |

A Service of the National Cancer Institute